IUPAC/Chemical Name
(12Z,32Z,102Z,202Z,6S,9Z,16S)-N-(3-((3-amino-3-oxoprop-1-en-2-yl)amino)-3-oxoprop-1-en-2-yl)-9-ethylidene-6-((R)-1-hydroxyethyl)-16-(2-hydroxypropan-2-yl)-105,205-dimethyl-13,19,23,26-tetramethylene-4,7,11,14,17,21,24-heptaoxo-5,8,12,15,18,22,25-heptaaza-1(4,2),10,20(2,4)-trioxazola-3(2,4)-thiazola-2(2,3)-pyridinacyclohexacosaphane-26-carboxamide
InChi Key
CAFFHXXVDGAVPH-DKFXDEMXSA-N
InChi Code
InChI=1S/C51H51N15O15S/c1-13-28-49-65-34(26(10)81-49)45(76)56-21(5)40(71)66-36(51(11,12)78)46(77)58-23(7)48-64-33(25(9)80-48)44(75)55-20(4)39(70)57-22(6)47-61-30(16-79-47)35-27(50-62-31(17-82-50)42(73)63-32(24(8)67)43(74)60-28)14-15-29(59-35)41(72)54-19(3)38(69)53-18(2)37(52)68/h13-17,24,32,36,67,78H,2-7H2,1,8-12H3,(H2,52,68)(H,53,69)(H,54,72)(H,55,75)(H,56,76)(H,57,70)(H,58,77)(H,60,74)(H,63,73)(H,66,71)/b28-13-/t24-,32+,36-/m1/s1
SMILES Code
O=C(NC(C(NC(C(N)=O)=C)=O)=C)C1=CC=C(C2=NC(C(N[C@]([C@@H](C)O)([H])C(N/C(C3=NC4=C(C)O3)=C\C)=O)=O)=CS2)C(C5=COC(C(NC(C(NC(C6=C(C)OC(C(NC([C@@H](NC(C(NC4=O)=C)=O)C(C)(O)C)=O)=C)=N6)=O)=C)=O)=C)=N5)=N1
Purity
>95% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
1,146.12
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Malcolmson SJ, Young TS, Ruby JG, Skewes-Cox P, Walsh CT. The posttranslational modification cascade to the thiopeptide berninamycin generates linear forms and altered macrocyclic scaffolds. Proc Natl Acad Sci U S A. 2013 May 21;110(21):8483-8. doi: 10.1073/pnas.1307111110. Epub 2013 May 6. PMID: 23650400; PMCID: PMC3666682.
2: Tistechok S, Myronovskyi M, Fedorenko V, Luzhetskyy A, Gromyko O. Screening of Thiopeptide-Producing Streptomycetes Isolated From the Rhizosphere Soil of Juniperus excelsa. Curr Microbiol. 2022 Sep 5;79(10):305. doi: 10.1007/s00284-022-03004-2. PMID: 36065025.
3: Sayanjali B, Christensen GJM, Al-Zeer MA, Mollenkopf HJ, Meyer TF, Brüggemann H. Propionibacterium acnes inhibits FOXM1 and induces cell cycle alterations in human primary prostate cells. Int J Med Microbiol. 2016 Nov;306(7):517-528. doi: 10.1016/j.ijmm.2016.06.006. Epub 2016 Jun 28. PMID: 27424770.
4: Thompson J, Cundliffe E, Stark MJ. The mode of action of berninamycin and mechanism of resistance in the producing organism, Streptomyces bernensis. J Gen Microbiol. 1982 Apr;128(4):875-84. doi: 10.1099/00221287-128-4-875. PMID: 6181185.
5: Lau RC, Rinehart KL. Berninamycins B, C, and D, minor metabolites from Streptomyces bernensis. J Antibiot (Tokyo). 1994 Dec;47(12):1466-72. doi: 10.7164/antibiotics.47.1466. Erratum in: J Antibiot (Tokyo) 1995 Mar;48(3):C-1. PMID: 7844041.
6: Liesch JM, Rinehart KL Jr. Berninamycin. 3. Total structure of berninamycin A1,2. J Am Chem Soc. 1977 Mar 2;99(5):1645-6. doi: 10.1021/ja00447a061. PMID: 839013.
7: Schneider O, Simic N, Aachmann FL, Rückert C, Kristiansen KA, Kalinowski J, Jiang Y, Wang L, Jiang CL, Lale R, Zotchev SB. Genome Mining of Streptomyces sp. YIM 130001 Isolated From Lichen Affords New Thiopeptide Antibiotic. Front Microbiol. 2018 Dec 19;9:3139. doi: 10.3389/fmicb.2018.03139. PMID: 30619207; PMCID: PMC6306032.
8: Liesch JM, Millington DS, Pandey RC, Rinehart KL Jr. Berninamycin. 2. Products of acidic hydrolysis, methanolysis, and acetolysis of berninamycin A1. J Am Chem Soc. 1976 Dec 8;98(25):8237-49. doi: 10.1021/ja00441a058. PMID: 993523.
9: Biskupiak JE, Meyers E, Gillum AM, Dean L, Trejo WH, Kirsch DR. Neoberninamycin, a new antibiotic produced by Micrococcus luteus. J Antibiot (Tokyo). 1988 May;41(5):684-7. doi: 10.7164/antibiotics.41.684. PMID: 3384754.
